Astral’s stock dipped 11% after announcing a demerger of its chemicals business. Investors are concerned about the valuation and growth prospects of the standalone chemical entity, which currently lags the profitable plumbing segment. While analysts maintain ‘buy’ ratings, some have lowered target prices. The company anticipates significant revenue growth for the chemicals division in the coming years.
SIPs offer steady gains as most fund categories beat benchmark indices
In the last two years, systematic investment plans have shown remarkable performance, with small-cap funds leading with an average return of 14.25%. Retail investor monthly
September 29, 2026